Antioxidant Effect of Cysteamine in Brain Cortex of Young Rats
- 189 Downloads
Cysteamine is a cystine-depleting drug used in the treatment of cystinosis, a metabolic disorder caused by deficiency of the lysosomal cystine carrier. As a result, cystine accumulates within lysosomes in many tissues and organs, including the nervous system. Studies with cystine dimethyl ester loaded cells suggest that cystine might induce apoptosis through oxidative stress. Our objective was to investigate the effects of co-administration of cysteamine with the oxidant cystine dimethyl ester on several parameters of oxidative stress in the brain cortex of rats. Animals were injected with 1.6 μmol/g cystine dimethyl ester and/or 0.26 μmol/g body weight cysteamine. Cystine dimethyl ester induced lipoperoxidation, protein carbonylation, and stimulated superoxide dismutase, glutathione peroxidase and catalase activities, probably through the formation of free radicals. Cysteamine prevented those effects, possibly increasing cellular thiol pool and acting as a scavenger of free radicals. These results suggest that the antioxidant effect of cysteamine may be important in the treatment of cystinosis.
KeywordsCysteamine Cystinosis Cystine dimethyl ester Cystine Oxidative stress Brain cortex
This work was supported in part by grants from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-Brazil), Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS, RS-Brazil), Programa de Núcleos de Excelência (PRONEX-CNPq /FAPERGS -Brazil) and Rede Instituto Brasileiro de Neurociência (IBN-Net), FINEP #01.06.0842-00.
- 3.Dominy JE, Simmons CR, Hirschberger LL et al (2007) Discovery and characterization of a second mammalian thiol dioxygenase: Cysteamine dioxygenase. J Biol Chem. Jun 20; [Epub ahead of print]Google Scholar
- 9.Gahl WA, Thoene JG, Schneider JA (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic & Molecular Bases of Inherited Diseases. McGraw- Hill, New York, pp 5085–5108Google Scholar
- 22.Foreman JW, Bowring MA, Lee J et al (1987) Effect of cystine dimethyl ester on renal solute handling and isolated renal tubule transport in the rat. A new model Fanconi syndrome Metab 36:1185–1191Google Scholar
- 23.Ben-Nun A, Bashan N, Potashnik R et al (1993) Cystine loading induces Fanconi’s syndrome in rats: in vivo and vesicle studies. Am J Physiol 265:839–844Google Scholar
- 25.Gonzalez Flecha B, Llesuy S, Boveris A (1991) Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle Free Radic. Biol Med 10(2):93–100Google Scholar
- 36.Leech NL, Barrett KC, Morgan GA (2005) SPSS for intermediate statistics. Use and interpretation, Lawrence Erlbaum Associates Publishers (ed), London, pp 46–62Google Scholar
- 39.Fox JH, Barber DS, Singh B, Zucker B, Swindell MK, Norflus F, Buzescu R, Chopra R, Ferrante RJ, Kazantsev A, Hersch SM. (2004) Cystamine increases L-cysteine levels in Huntington’s disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation. J Neurochem 91:413–422PubMedCrossRefGoogle Scholar
- 40.Winterbourn CC, Metodiewa CD (1999) Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide Free Radic. Biol Med 27:322–328Google Scholar
- 49.Tardy C, Andrieu-Abadie N, Salvayre R et al (2004) Lysosomal storage diseases: is impaired apoptosis a pathogenic mechanism? Neurochem. Res 29:871–880Google Scholar